GI Longevity’s preclinical study center specialized in preclinical CRDO service
GI Longevity’s preclinical study center, a research institute for in vivo mouse efficacy test,
provides PK/PD and tox study consulting and CRDO service of new drug candidates and has various networks
related to efficacy evaluation for one stop preclinical study service
The state-of-the-art animal facility that enables GI Longevity to conduct multiple
CRDO projects simultaneously and quickly
| Size |
|
|---|---|
| Location | GI Longevity headquarter 1st basement |
| Approval |
|
| Major research |
|
Why GI Longevity CRDO?
Specialized in humanized mouse model test and data packaging for clinical trial and technology transfer
One stop service from animal test design to immune profiling design and analysis
State of the art facility for systematic monitoring and managing preclinical studies
Animal test models for various kinds of diseases and tailored in vivo models
for CRDO service
Cancer
Breast cancer
Colon cancer
Lung cancer
Brain cancer
Liver cancer
Lymphoma cancer
Ovarian cancer
Renal disease
Acute renal failure : Ischemia-reperfusion injury model / Doxorubicin model
Chronic renal failure : Unilateral ureteral obstruction / Doxorubicin model / 5/6 nephrectomy model
Intestinal disease
Naive T cell transfer
DSS induced colitis
Oxazolone induced colitis
TNBS induced colitis
Liver disease
NASH(non-alcoholic steatohepatitis)
Hepatic fibrosis
Metabolic disease
Streptozotocin-induced model
Diet-induced model (Obesity)
CNS disease
Scopolamine-induced amnesia
Chronic restraint stress-induced depression model
Chronic constriction injury
Critical limb ischemia model
Immune disesae
Psoriasis
Atopic dermatitis
Passive cutaneous / systemic anaphylaxis
Food allergy / Food-induced anaphylaxis
Multiple sclerosis (EAE)
Allergic conjunctivitis
Rheumatoid arthritis
Respiratory / Circulatory disease
chronic obstructive pulmonary disease
Pulmonary fibrosis
Wound healing model (splint used mouse model)
Angiotensin II-induced atherosclerosis